Rafael de la Torre Selected Research

4-hydroxyphenylethanol

10/2021	Effects of Wine and Tyrosol on the Lipid Metabolic Profile of Subjects at Risk of Cardiovascular Disease: Potential Cardioprotective Role of Ceramides.
5/2015	Ethanol induces hydroxytyrosol formation in humans.
9/2010	Antioxidant activities of hydroxytyrosol main metabolites do not contribute to beneficial health effects after olive oil ingestion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rafael de la Torre Research Topics

Disease

13	Cognitive Dysfunction 01/2022 - 01/2011
10	Obesity 01/2022 - 02/2012
10	Cardiovascular Diseases (Cardiovascular Disease) 10/2021 - 11/2009
8	Down Syndrome (Down's Syndrome) 02/2020 - 01/2012
7	Substance-Related Disorders (Drug Abuse) 04/2022 - 01/2004
6	Cocaine-Related Disorders (Cocaine Addiction) 07/2021 - 11/2013
6	Mental Disorders (Mental Disorder) 02/2021 - 01/2013
5	Body Weight (Weight, Body) 01/2020 - 01/2013
5	Inflammation (Inflammations) 01/2020 - 07/2010
5	Atherosclerosis 12/2015 - 02/2009
4	Neoplasms (Cancer) 01/2022 - 01/2007
4	COVID-19 08/2021 - 01/2020
4	Fragile X Syndrome (Martin Bell Syndrome) 01/2021 - 05/2013
4	Alcoholism (Alcohol Abuse) 10/2020 - 09/2017
3	Overweight 01/2022 - 01/2018
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022 - 10/2007
3	Insulin Resistance 01/2021 - 08/2007
3	Alzheimer Disease (Alzheimer's Disease) 12/2020 - 01/2015
3	Schizophrenia (Dementia Praecox) 12/2020 - 07/2014
3	Morbid Obesity 12/2019 - 11/2017
3	Mood Disorders (Mood Disorder) 01/2019 - 01/2010
3	Intellectual Disability (Idiocy) 01/2018 - 05/2013
2	Neuroinflammatory Diseases 02/2022 - 10/2019
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2022 - 05/2018
2	Weight Loss (Weight Reduction) 08/2021 - 01/2020
2	Type 2 Diabetes Mellitus (MODY) 01/2021 - 01/2021
2	Fatty Liver 01/2017 - 10/2015
2	Anorexia Nervosa 03/2016 - 09/2015
2	Feeding and Eating Disorders (Eating Disorder) 02/2016 - 01/2013
2	Drug-Related Side Effects and Adverse Reactions 10/2015 - 02/2010
2	Seizures (Absence Seizure) 02/2015 - 05/2013
2	Anxiety Disorders (Anxiety Disorder) 01/2015 - 11/2013
2	Gambling (Pathological Gambling) 12/2014 - 10/2014
2	Bulimia Nervosa 08/2014 - 11/2013
2	Hyperthermia 04/2008 - 04/2008
1	Chronic Disease (Chronic Diseases) 02/2022
1	Pathologic Processes 01/2022
1	Vitamin B 6 Deficiency (Pyridoxine Deficiency) 01/2022
1	Multiple Sclerosis 01/2022
1	Adrenoleukodystrophy (Adrenoleukodystrophy, X-Linked) 01/2022
1	Peripheral Arterial Disease 10/2021
1	Pneumonia (Pneumonitis) 08/2021

Drug/Important Bio-Agent (IBA)

16	Olive OilIBA 07/2019 - 01/2007
11	EndocannabinoidsIBA 01/2022 - 01/2013
11	Biomarkers (Surrogate Marker)IBA 10/2021 - 11/2013
8	LipidsIBA 01/2022 - 11/2013
7	Proteins (Proteins, Gene)FDA Link 04/2021 - 02/2010
7	Pharmaceutical PreparationsIBA 10/2015 - 01/2004
6	Biological ProductsIBA 01/2020 - 10/2009
6	Cocaine (Cocaine HCl)IBA 07/2015 - 03/2007
6	N-Methyl-3,4-methylenedioxyamphetamine (MDMA)IBA 01/2011 - 04/2004
5	CannabinoidsIBA 01/2021 - 01/2013
5	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 01/2021 - 07/2016
4	3,4-dihydroxyphenylethanol (hydroxytyrosol)IBA 12/2015 - 09/2010
3	Fatty Acids (Saturated Fatty Acids)IBA 01/2022 - 01/2013
3	EnzymesIBA 01/2022 - 02/2010
3	4-hydroxyphenylethanolIBA 10/2021 - 09/2010
3	Peptides (Polypeptides)IBA 03/2016 - 01/2015
3	Glucose (Dextrose)FDA LinkGeneric 09/2015 - 07/2014
3	oxidized low density lipoproteinIBA 07/2015 - 09/2010
3	CholesterolIBA 01/2015 - 07/2014
2	lysophosphatidic acidIBA 04/2022 - 10/2020
2	Cholecystokinin (Pancreozymin)IBA 02/2022 - 02/2016
2	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2022 - 01/2018
2	Indicators and Reagents (Reagents)IBA 10/2021 - 08/2021
2	IsoflavonesIBA 07/2021 - 01/2019
2	Fragile X Mental Retardation ProteinIBA 01/2021 - 05/2013
2	Analgesics (Analgesic Drugs)IBA 01/2021 - 10/2020
2	Insulin (Novolin)FDA Link 01/2021 - 09/2015
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2020 - 01/2015
2	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 12/2019 - 12/2017
2	Monoacylglycerol LipasesIBA 10/2019 - 01/2013
2	Ethanol (Ethyl Alcohol)IBA 01/2019 - 05/2015
2	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 11/2018 - 01/2013
2	Oleic Acid (Oleate)IBA 11/2018 - 10/2015
2	Acetaminophen (Paracetamol)FDA LinkGeneric 12/2017 - 11/2017
2	Caffeine (No Doz)FDA LinkGeneric 12/2017 - 11/2017
2	oleoylethanolamideIBA 09/2017 - 01/2015
2	OrexinsIBA 11/2016 - 03/2016
2	DNA (Deoxyribonucleic Acid)IBA 10/2016 - 01/2007
2	Amphetamine (Amfetamine)FDA LinkGeneric 10/2015 - 01/2004
2	PolyphenolsIBA 07/2015 - 05/2012
2	AntioxidantsIBA 07/2015 - 09/2010
2	CytokinesIBA 07/2015 - 01/2015
2	Triglycerides (Triacylglycerol)IBA 01/2015 - 08/2007
2	Interleukin-6 (Interleukin 6)IBA 01/2015 - 09/2013
1	Triggering Receptor Expressed on Myeloid Cells-1IBA 02/2022
1	GastrinsIBA 02/2022
1	Carboxylic AcidsIBA 01/2022
1	Member 1 Subfamily D ATP Binding Cassette TransporterIBA 01/2022
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 01/2022
1	Vitamin K FDA Link 01/2022
1	SphingolipidsIBA 10/2021
1	CeramidesIBA 10/2021

Therapy/Procedure

14	Mediterranean Diet 02/2022 - 01/2007
6	Therapeutics 11/2018 - 01/2012
4	Cognitive Training 01/2021 - 07/2016
3	Bariatric Surgery 12/2019 - 11/2017
2	Glycemic Control 01/2021 - 01/2021
2	Fat-Restricted Diet (Diet, Fat Restricted) 05/2014 - 06/2007